07 Feb 2022 --- Nestlé Health Science (NHSc) is growing its weight management portfolio with the purchase of PronoKal from Abac Capital. PronoKal is an “applied genomics” weight loss app with a strong base in southern Europe. The system, supported by doctors, offers consumers a personalized ketogenic diet and fitness plan, helping them lose up to 9 kg per month.
